Windlas Biotech Limited is tapping the capital markets with its fresh issue of Rs 165 crs and an offer for sale of 51,42,067 equity shares in a price band of Rs 448-460. The company completed its allocation to anchor investors by allotting 26,18,706 equity shares at Rs 460 to 12 anchor investors comprising of 22 entities.

The highest allocation was made ICICI Prudential Pharma Healthcare Fund of 5,43,450 equity shares or 20.75% of the anchor allocation. This was followed by an equal allotment of 2,17,410 shares or 8.30% to 8 anchors. This implies that the top nine anchors were allotted 87.15% of the anchor portion.

The issue opens on Wednesday the 4th of August and closes on Friday the 6th of August.

The full details of the anchor allotment are given below: –